Effect of transvenous cardiac resynchronization therapy device implantation on cardiac troponin I release

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 11, 2007, Pages 1356-1362

  Altin, Timucin ^a   Akyurek, Omer ^a   Vurgun, Kutay ^a   Beton, Osman ^a   Sayin, Tamer ^a   Kilickap, Mustafa ^a   Karaoguz, Remzi ^a   Guldal, Muharrem ^a   Erol, Cetin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cardiac resynchronization therapy; Cardiac troponin I

Indexed keywords

TROPONIN I;

ADULT; AGED; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD SAMPLING; CARDIAC RESYNCHRONIZATION THERAPY; CONTROL GROUP; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; TROPONIN BLOOD LEVEL;

AGED; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PACEMAKER, ARTIFICIAL; PROSTHESIS IMPLANTATION; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35748981476     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00871.x     Document Type: Article

References (20)

1. Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med 2003 26: 133 147.
2. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 36: 959 969.
3. Boos CJ, Gough S, Wheather M, Medbak S, More R. Effects of transvenous pacing on cardiac troponin release. Pacing Clin Electrophysiol 2004 27: 1264 1268.
4. Nikolaou NI, Spanodimos SG, Tsaglis EP, Antonatos DG, Patsilinakos SP, Fournarakis GM, Tsigas D. Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead. Pacing Clin Electrophysiol 2005 28: 1174 1181.
5. Dworschak M, Franz M, Khazen C, Czerny M, Haisackl M, Hiesmayr M. Mechanical trauma as the major cause of troponin T release after transvenous implantation of cardioverter/defibrillators. Cardiology 2001 99: 212 214.
6. Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 2003 108: 1044 1048.
7. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2005 46: 1 82.
8. Vollmer RT, Christenson RH, Reimer K, Ohman EM. Temporal creatine kinase curves in acute myocardial infarction: Implications of a good empiric fit with the log-normal function. Am J Clin Pathol 1993 100: 293 298.
9. Eisenman A. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: Where do we stand? Expert Rev Cardiovasc Ther 2006 4: 509 514.
10. Butter C, Gras D, Ritter P, Stellbrink C, Fleck E, Tockman B, Schubert B, et al. Comparative prospective randomized efficacy testing of different guiding catheters for coronary sinus cannulation in heart failure patients. J Interv Card Electrophysiol 2003 9: 343 351.
11. De Martino G, Messano L, Santamaria M, Parisi Q, Russo AD, Pelargonio G, Sanna T, et al. A randomized evaluation of different approaches to coronary sinus venography during biventricular pacemaker implants. Europace 2005 7: 73 76.
12. Meisel E, Pfeiffer D, Engelmann L, Tebbenjohanns J, Schubert B, Hahn S, Fleck E, et al. Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation 2001 104: 442 447.
13. Cowburn PJ, Patel H, Pipes RR, Parker JD. Contrast nephropathy post cardiac resynchronization therapy: An under-recognized complication with important morbidity. Eur J Heart Fail 2005 7: 899 903.
14. Lee HC, Yen HW, Sheu SH. Effects of different contrast media on glutathione peroxidase and superoxide dismutase activities in the heart and kidneys of normal and streptozotocin-induced diabetic rats. J Formos Med Assoc 2006 105: 530 535.
15. Wisneski JA, Gertz EW, Neese RA, Morris DL. Absence of myocardial biochemical toxicity with a non ionic contrast agent (iopamidol). Am Heart J 1985 110: 609 617.
16. Lin CT, Lee HC, Voon WC, Yen HW, Tang MH, Chin TT, Chen WR, et al. Positive interference from contrast media in cardiac troponin I immunoassays. Kaohsiung J Med sci 2006 22: 107 113.
17. Bakshi TK, Choo MKF, Edwards CC, Scott AG, Hart HH, Armstrong GP. Causes of elevated troponin I with normal coronary angiogram. Intern Med J 2002 32: 520 525.
18. Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti J, Bourgoin P, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 2001 141: 247 253.
19. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999 34: 402 408.
20. Apple FS. Tissue specifity of cardiac troponin I, cardiac troponin T, and creatine kinase-MB. Clin Chim Acta 1999 284: 151 159.